2026 Q2 - tulosraportti
80 päivää sitten
‧1 t 2 min
3,75 DKK/osake
Viimeisin osinko
4,42%Tuotto/v
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 6 | - | - | ||
| 1 | - | - | ||
| 18 | - | - | ||
| 218 | - | - | ||
| 324 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 5.8. | ||
2026 Q1 - tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 - tulosraportti 4.2. | ||
2025 Q3 - tulosraportti 5.11.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
·7 t sitten · MuokattuWhat is Novo's Public Relations department actually doing. I find it a pity and a shame that they don't have a more American approach to new initiatives and groundbreaking trials. Sell yourselves big, unlike old innovations you have now entered the fast lane and your market shares are now also about the general market with products for the masses. There is no room for the Law of Jante here.. The stock market is American in all its understanding, - purchases are made from those who are heard and those who sell themselves best. Get that department up from the basement now. I am not Pro-American in any way, quite the contrary, but the new miracle remedies are not just for health, it is also about vanity and it is bought by people driven by emotions. When competitors lay it on thick - then you have to keep up. I think people at Novo fear making a misstep, but nothing ventured, nothing gained. And sell yourselves on being Danish - we actually have a good reputation out there in the big wide world. Which is not so big anymore. It is also humans sitting behind the large pension funds, hedge funds and institutions. Those who start the snowball. Can we please see that Novo truck in the Christmas commercials (ref: Coca Cola ) (irony may occur)
- ·14 t sittenNovo Nordisks Awiqli® får FDA-godkendelse som den første og eneste insulin til dosering én gang om ugen til børn fra 10 år med type 2-diabetes - Awiqli® giver børn fra 10 år et alternativ til basalinsulin med ugentlig dosering, hvilket reducerer antallet af basale insulininjektioner fra syv gange om ugen til én gang om ugen. - **Forekomsten af type 2-diabetes blandt børn og unge fortsætter med at stige.**² Awiqli® kan bidrage til at mindske de praktiske barrierer forbundet med daglige injektioner af basalinsulin og give familier adgang til en mere individuelt tilpasset behandling. - Godkendelsen af Awiqli® afspejler Novo Nordisks fortsatte indsats for at fremme innovation i sundhedsvæsenet og styrke støtten til mennesker, der lever med diabetes, samt deres pårørende og omsorgspersoner.
Stockraider only wants to argue and nothing else, doesn't contribute anything at all! - ·22 t sittenIt is sort of like Groundhog day keeping up with things in here regarding Novo. There are 3 teams in here. Those who grasp at every straw to convince themselves that now it is turning around. As if writing about positive statements helps lift the share price along. Sorry to say it friends, your comments do not move 4.6 billion shares in any direction. Then there are You who lie in wait and just wait for the price to drop so you can hunt down your compatriots and condescendingly comment that now the price is heading down to the 200s which you know it is going down to. You do not know anything about what the right price is. None of us do. You simply read what the analysts think it should be and then reproduce everything you hear out there. And then there are all the rest of us who know well that the price is controlled by greater forces. We can simply get in the wagon and hope that tomorrow reveals that the powers will now move the money over here. Common among all 3 groups is that many of us have lost a lot of money on Novo, we just have different ways of dealing with it.. All of it is reflected in powerlessness, which manifests differently in humans.
·1 päivä sittenIf I read that all overweight people in the USA exclusively used Novo preparations, that not a single prescription for Lilly was issued - and observed that this did not move Novo's share price upwards - well, then I would sit with the exact same calm feeling in my body. The market can - and does - do something that I cannot (nor understand). But it is obvious that the price will shoot up again. The Novo top management is of course not sitting on their hands - I believe in the announced blockbusters! So if there are any out there who have simply invested too wildly or too recklessly, then take the ride along - or sell!
Has Novo mentioned just one of the five possible blockbusters within the next 3-4 years. For they surely don't all come in 2030, and there must surely be at least a little substance behind this statement. 5 blockbusters is after all quite a claim. ......now Novo hasn't really hit with anything at all for two years. The market downgraded the quarterly reports at least one month before Novo did it.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
80 päivää sitten
‧1 t 2 min
3,75 DKK/osake
Viimeisin osinko
4,42%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·7 t sitten · MuokattuWhat is Novo's Public Relations department actually doing. I find it a pity and a shame that they don't have a more American approach to new initiatives and groundbreaking trials. Sell yourselves big, unlike old innovations you have now entered the fast lane and your market shares are now also about the general market with products for the masses. There is no room for the Law of Jante here.. The stock market is American in all its understanding, - purchases are made from those who are heard and those who sell themselves best. Get that department up from the basement now. I am not Pro-American in any way, quite the contrary, but the new miracle remedies are not just for health, it is also about vanity and it is bought by people driven by emotions. When competitors lay it on thick - then you have to keep up. I think people at Novo fear making a misstep, but nothing ventured, nothing gained. And sell yourselves on being Danish - we actually have a good reputation out there in the big wide world. Which is not so big anymore. It is also humans sitting behind the large pension funds, hedge funds and institutions. Those who start the snowball. Can we please see that Novo truck in the Christmas commercials (ref: Coca Cola ) (irony may occur)
- ·14 t sittenNovo Nordisks Awiqli® får FDA-godkendelse som den første og eneste insulin til dosering én gang om ugen til børn fra 10 år med type 2-diabetes - Awiqli® giver børn fra 10 år et alternativ til basalinsulin med ugentlig dosering, hvilket reducerer antallet af basale insulininjektioner fra syv gange om ugen til én gang om ugen. - **Forekomsten af type 2-diabetes blandt børn og unge fortsætter med at stige.**² Awiqli® kan bidrage til at mindske de praktiske barrierer forbundet med daglige injektioner af basalinsulin og give familier adgang til en mere individuelt tilpasset behandling. - Godkendelsen af Awiqli® afspejler Novo Nordisks fortsatte indsats for at fremme innovation i sundhedsvæsenet og styrke støtten til mennesker, der lever med diabetes, samt deres pårørende og omsorgspersoner.Stockraider only wants to argue and nothing else, doesn't contribute anything at all!
- ·22 t sittenIt is sort of like Groundhog day keeping up with things in here regarding Novo. There are 3 teams in here. Those who grasp at every straw to convince themselves that now it is turning around. As if writing about positive statements helps lift the share price along. Sorry to say it friends, your comments do not move 4.6 billion shares in any direction. Then there are You who lie in wait and just wait for the price to drop so you can hunt down your compatriots and condescendingly comment that now the price is heading down to the 200s which you know it is going down to. You do not know anything about what the right price is. None of us do. You simply read what the analysts think it should be and then reproduce everything you hear out there. And then there are all the rest of us who know well that the price is controlled by greater forces. We can simply get in the wagon and hope that tomorrow reveals that the powers will now move the money over here. Common among all 3 groups is that many of us have lost a lot of money on Novo, we just have different ways of dealing with it.. All of it is reflected in powerlessness, which manifests differently in humans.
- ·1 päivä sittenIf I read that all overweight people in the USA exclusively used Novo preparations, that not a single prescription for Lilly was issued - and observed that this did not move Novo's share price upwards - well, then I would sit with the exact same calm feeling in my body. The market can - and does - do something that I cannot (nor understand). But it is obvious that the price will shoot up again. The Novo top management is of course not sitting on their hands - I believe in the announced blockbusters! So if there are any out there who have simply invested too wildly or too recklessly, then take the ride along - or sell!Has Novo mentioned just one of the five possible blockbusters within the next 3-4 years. For they surely don't all come in 2030, and there must surely be at least a little substance behind this statement. 5 blockbusters is after all quite a claim. ......now Novo hasn't really hit with anything at all for two years. The market downgraded the quarterly reports at least one month before Novo did it.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 6 | - | - | ||
| 1 | - | - | ||
| 18 | - | - | ||
| 218 | - | - | ||
| 324 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 5.8. | ||
2026 Q1 - tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 - tulosraportti 4.2. | ||
2025 Q3 - tulosraportti 5.11.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
80 päivää sitten
‧1 t 2 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 5.8. | ||
2026 Q1 - tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 - tulosraportti 4.2. | ||
2025 Q3 - tulosraportti 5.11.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
3,75 DKK/osake
Viimeisin osinko
4,42%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·7 t sitten · MuokattuWhat is Novo's Public Relations department actually doing. I find it a pity and a shame that they don't have a more American approach to new initiatives and groundbreaking trials. Sell yourselves big, unlike old innovations you have now entered the fast lane and your market shares are now also about the general market with products for the masses. There is no room for the Law of Jante here.. The stock market is American in all its understanding, - purchases are made from those who are heard and those who sell themselves best. Get that department up from the basement now. I am not Pro-American in any way, quite the contrary, but the new miracle remedies are not just for health, it is also about vanity and it is bought by people driven by emotions. When competitors lay it on thick - then you have to keep up. I think people at Novo fear making a misstep, but nothing ventured, nothing gained. And sell yourselves on being Danish - we actually have a good reputation out there in the big wide world. Which is not so big anymore. It is also humans sitting behind the large pension funds, hedge funds and institutions. Those who start the snowball. Can we please see that Novo truck in the Christmas commercials (ref: Coca Cola ) (irony may occur)
- ·14 t sittenNovo Nordisks Awiqli® får FDA-godkendelse som den første og eneste insulin til dosering én gang om ugen til børn fra 10 år med type 2-diabetes - Awiqli® giver børn fra 10 år et alternativ til basalinsulin med ugentlig dosering, hvilket reducerer antallet af basale insulininjektioner fra syv gange om ugen til én gang om ugen. - **Forekomsten af type 2-diabetes blandt børn og unge fortsætter med at stige.**² Awiqli® kan bidrage til at mindske de praktiske barrierer forbundet med daglige injektioner af basalinsulin og give familier adgang til en mere individuelt tilpasset behandling. - Godkendelsen af Awiqli® afspejler Novo Nordisks fortsatte indsats for at fremme innovation i sundhedsvæsenet og styrke støtten til mennesker, der lever med diabetes, samt deres pårørende og omsorgspersoner.Stockraider only wants to argue and nothing else, doesn't contribute anything at all!
- ·22 t sittenIt is sort of like Groundhog day keeping up with things in here regarding Novo. There are 3 teams in here. Those who grasp at every straw to convince themselves that now it is turning around. As if writing about positive statements helps lift the share price along. Sorry to say it friends, your comments do not move 4.6 billion shares in any direction. Then there are You who lie in wait and just wait for the price to drop so you can hunt down your compatriots and condescendingly comment that now the price is heading down to the 200s which you know it is going down to. You do not know anything about what the right price is. None of us do. You simply read what the analysts think it should be and then reproduce everything you hear out there. And then there are all the rest of us who know well that the price is controlled by greater forces. We can simply get in the wagon and hope that tomorrow reveals that the powers will now move the money over here. Common among all 3 groups is that many of us have lost a lot of money on Novo, we just have different ways of dealing with it.. All of it is reflected in powerlessness, which manifests differently in humans.
- ·1 päivä sittenIf I read that all overweight people in the USA exclusively used Novo preparations, that not a single prescription for Lilly was issued - and observed that this did not move Novo's share price upwards - well, then I would sit with the exact same calm feeling in my body. The market can - and does - do something that I cannot (nor understand). But it is obvious that the price will shoot up again. The Novo top management is of course not sitting on their hands - I believe in the announced blockbusters! So if there are any out there who have simply invested too wildly or too recklessly, then take the ride along - or sell!Has Novo mentioned just one of the five possible blockbusters within the next 3-4 years. For they surely don't all come in 2030, and there must surely be at least a little substance behind this statement. 5 blockbusters is after all quite a claim. ......now Novo hasn't really hit with anything at all for two years. The market downgraded the quarterly reports at least one month before Novo did it.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 6 | - | - | ||
| 1 | - | - | ||
| 18 | - | - | ||
| 218 | - | - | ||
| 324 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt